Mesenchymal Stem Cells and Their Extracellular Vesicles: Therapeutic Mechanisms for Blood–Spinal Cord Barrier Repair Following Spinal Cord Injury
International Journal of Molecular Sciences · 16.12.2024 · 25 (24) · 13460
DOI: 10.3390/ijms252413460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.12.2024. Verfasst von Masahito Nakazaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Spinal Cord. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Tech Foundation, JSPS KAKENHI grant, RR&D and BLR&D Services of the U.S. Department of Veterans Affairs,.
Abstract (Originalsprache)
Spinal cord injury (SCI) disrupts the blood–spinal cord barrier (BSCB) exacerbating damage by allowing harmful substances and immune cells to infiltrate spinal neural tissues from the vasculature. This leads to inflammation, oxidative stress, and impaired axonal regeneration. The BSCB, essential for maintaining spinal cord homeostasis, is structurally similar to the blood–brain barrier. Its restoration is a key therapeutic target for improving outcomes in SCI. Mesenchymal stromal/stem cells (MSCs) and their secreted extracellular vesicles (MSC-EVs) have gained attention for their regenerative, immunomodulatory, and anti-inflammatory properties in promoting BSCB repair. MSCs enhance BSCB integrity by improving endothelial–pericyte association, restoring tight junction proteins, and reducing inflammation. MSC-EVs, which deliver bioactive molecules, replicate many of MSCs’ therapeutic effects, and offer a promising cell-free alternative. Preclinical studies have shown that both MSCs and MSC-EVs can reduce BSCB permeability, promote vascular stability, and support functional recovery. While MSC therapy is advancing in clinical trials, MSC-EV therapies require further optimization in terms of production, dosing, and delivery protocols. Despite these challenges, both therapeutic approaches represent significant potential for treating SCI by targeting BSCB repair and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.
- Department of Neurology, Yale University School of Medicine, New Haven, CT 06510, USA.
- Center for Neuroscience and Regeneration Research, VA Connecticut Healthcare System, West Haven, CT 06516, USA.
ORCID-Profile: Masahito Nakazaki, Takahiro Yokoyama, Ryosuke Hirota, Jeffery D Kocsis
Förderung
- North Tech Foundation
- JSPS KAKENHI grant
- RR&D and BLR&D Services of the U.S. Department of Veterans Affairs,
- RR&D and BLR&D Services of the U.S. Department of Veterans Affairs
- RR&D and BLR&D Services of the U.S. Department of Veterans Affairs
Zitieren
APA
Nakazaki, M., Yokoyama, T., Lankford, K. L., Hirota, R., Kocsis, J. D., & Honmou, O. (2024). Mesenchymal Stem Cells and Their Extracellular Vesicles: Therapeutic Mechanisms for Blood–Spinal Cord Barrier Repair Following Spinal Cord Injury. International Journal of Molecular Sciences, 25(24), 13460. https://doi.org/10.3390/ijms252413460
Vancouver
Nakazaki M, Yokoyama T, Lankford KL, Hirota R, Kocsis JD, Honmou O. Mesenchymal Stem Cells and Their Extracellular Vesicles: Therapeutic Mechanisms for Blood–Spinal Cord Barrier Repair Following Spinal Cord Injury. International Journal of Molecular Sciences. 2024;25(24):13460. doi:10.3390/ijms252413460
BibTeX
@article{Nakazaki2024,
author = {Nakazaki, Masahito and Yokoyama, Takahiro and Lankford, Karen L and Hirota, Ryosuke and Kocsis, Jeffery D and Honmou, Osamu},
title = {Mesenchymal Stem Cells and Their Extracellular Vesicles: Therapeutic Mechanisms for Blood–Spinal Cord Barrier Repair Following Spinal Cord Injury},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {24},
pages = {13460},
doi = {10.3390/ijms252413460}
}
EUVIMED